Nervous system complications in HIV infection

Neurological complications in patients with Human Immunodeficiency Virus infection

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/04/051412

Enrollment

100

Registered

2023-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PLWH patients diagnosed as per NACO guidelines, presenting with neurological manifestations of HIV Age greater than or equal to 18

Exclusion criteria

Exclusion criteria: Patients with Traumatic brain injury Patients with any other comorbidities/diseases causing neurological manifestationsvunrelated to HIV Patient not providing consent.

Design outcomes

Primary

Measure	Time frame
To document the neurological complications in HIV infection in terms of clinical, laboratory and radiological findingsTimepoint: At the end of study period	—

Secondary

Measure	Time frame
To study the occurrence of neurological complications in patients on HAART. To compare the occurrence of neurological complications in drug naÃ¯ve patients vs patients on HAART. To compare the clinico-radiological profile of CNS toxoplasmosis and CNS tuberculosisTimepoint: At the end of study	—

Countries

India

Contacts

Public ContactDr Nandakrishna B

Kasurba Medical College, Manipal

nanda.bhat@manipal.edu9914201838

Outcome results